Granules India informs about disclosure

23 Jul 2022 Evaluate

Granules India has informed that the US FDA has completed an inspection of the facility of Granules Pharmaceuticals, Inc., a wholly-owned foreign subsidiary of the Company located in Chantilly, Virginia, the USA on 22nd July 2022 with six (6) observations. Granules Pharmaceuticals, Inc. will respond to these observations within the stipulated time period.

The above information is a part of company’s filings submitted to BSE.

Granules India Share Price

603.30 -14.00 (-2.27%)
29-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1717.50
Dr. Reddys Lab 1268.60
Cipla 1494.40
Zydus Lifesciences 904.00
Lupin 2079.50
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×